Pneumonitis after chemoradiation and adjuvant durvalumab in stage III non-small-cell lung cancer

By sjmartinez • October 5, 2023

Edwards DM, Sankar K, Alseri A, Jiang R, Schipper M, Miller S, Dess K, Strohbehn GW, Elliott DA, Moghanaki D, Ramnath N, Green MD, Bryant AK. Pneumonitis after chemoradiation and adjuvant durvalumab in stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2023 Oct 2:S0360-3016(23)07971-3. doi: 10.1016/j.ijrobp.2023.09.050. Epub ahead of print. PMID: 37793573.

Tags: Cardiology/Epi, Cedars Sinai DoM, Publications

Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension

Hoeper MM, Ewert R, Jansa P, Sirenko Y, Skride A, Balagtas C, Hackley S, Vogt S, Abreu P, Haughie S, Hassan T, Oudiz RJ. Randomized,[...]

In-hospital and readmission outcomes of patients with cancer admitted for pulmonary embolism treated with or without catheter-based therapy

Leiva O, Yang EH, Rosovsky RP, Alviar C, Bangalore S. In-hospital and readmission outcomes of patients with cancer admitted for pulmonary embolism treated with or[...]

FAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysis

Maliha PG, Hotta M, Farolfi A, Grogan T, Alano R, Limon A, Lam E, Carlucci G, Bahri S, Salavati A, Benz M, Silverman D, Gupta[...]